Esoteric Testing Market Technological Advancements, Rising Chronic Diseases, and Personalized <a target=_blank href= ...

"Our air conditioners have been controlling temperature and humidity, but maybe the air conditioners of tomorrow will also ...

Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Ultragenyx Pharmaceutical in a ...

Surfactant B deficiency causes abnormalities in the lining of the lung tissues, making breathing difficult. The life expectancy without a lung transplant is about three to five months. In Kylie’s case ...

Recently, a member* of Reddit posed the question, "What’s the one random genetic trait you lucked out on?" to the good folks of r/AskReddit. Here are their top-voted wild, funny, and, frankly, envious ...

Angelman Syndrome is a rare genetic disorder caused by UBE3A gene mutations, leading to developmental delays, speech issues, ...

Mikey has exceeded expectations to become a little boy who loves the outdoors, eating pizza and spending time with his family ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

Now considered the most prevalent rare genetic disorder, there are actually 186 symptoms for 22q11 Deletion Syndrome, but ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.